Pfizer, Warner Lambert settle with direct purchasers for $190 million in Neurontin antitrust case
MLex Summary: Pfizer and Warner Lambert have agreed to pay $190 million to settle allegations that the drugmakers conspired to delay generic entry of the drug Neurontin, plaintiffs' lawyers representing direct...To view the full article, register now.
Already a subscriber? Click here to view full article